These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36498882)

  • 1. Potential of Non-Coding RNA as Biomarkers for Progressive Supranuclear Palsy.
    Simoes FA; Joilin G; Peters O; Schneider LS; Priller J; Spruth EJ; Vogt I; Kimmich O; Spottke A; Hoffmann DC; Falkenburger B; Brandt M; Prudlo J; Brockmann K; Fries FL; Rowe JB; Church A; Respondek G; Newbury SF; Leigh PN; Morris HR; Höglinger GU; Hafezparast M
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36498882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profiling non-coding RNA expression in cerebrospinal fluid of amyotrophic lateral sclerosis patients.
    Joilin G; Gray E; Thompson AG; Talbot K; Leigh PN; Newbury SF; Turner MR; Hafezparast M
    Ann Med; 2022 Dec; 54(1):3069-3078. PubMed ID: 36314539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cerebrospinal fluid microRNA analysis: Progressive supranuclear palsy.
    Nonaka W; Takata T; Iwama H; Komatsubara S; Kobara H; Kamada M; Deguchi K; Touge T; Miyamoto O; Nakamura T; Itano T; Masaki T
    Mol Med Rep; 2022 Mar; 25(3):. PubMed ID: 35039873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a potential non-coding RNA biomarker signature for amyotrophic lateral sclerosis.
    Joilin G; Gray E; Thompson AG; Bobeva Y; Talbot K; Weishaupt J; Ludolph A; Malaspina A; Leigh PN; Newbury SF; Turner MR; Hafezparast M
    Brain Commun; 2020; 2(1):fcaa053. PubMed ID: 32613197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosomal miRNA as peripheral biomarkers in Parkinson's disease and progressive supranuclear palsy: A pilot study.
    Manna I; Quattrone A; De Benedittis S; Vescio B; Iaccino E; Quattrone A
    Parkinsonism Relat Disord; 2021 Dec; 93():77-84. PubMed ID: 34839044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. microRNA profiling: increased expression of miR-147a and miR-518e in progressive supranuclear palsy (PSP).
    Tatura R; Buchholz M; Dickson DW; van Swieten J; McLean C; Höglinger G; Müller U
    Neurogenetics; 2016 Jul; 17(3):165-71. PubMed ID: 27052995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical value of CSF amyloid-beta-42 and tau proteins in Progressive Supranuclear Palsy.
    Schirinzi T; Sancesario GM; Di Lazzaro G; Scalise S; Colona VL; Imbriani P; Mercuri NB; Bernardini S; Lang AE; Pisani A
    J Neural Transm (Vienna); 2018 Sep; 125(9):1373-1379. PubMed ID: 29948175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA as Candidate Biomarkers in Atypical Parkinsonian Syndromes: Systematic Literature Review.
    Bougea A
    Medicina (Kaunas); 2022 Mar; 58(4):. PubMed ID: 35454322
    [No Abstract]   [Full Text] [Related]  

  • 9. Plasma microRNAs as a Potential Biomarker for Identification of Progressive Supranuclear Palsy.
    Ramaswamy P; Christopher R; Kumar Pal P; Debnath M; Yadav R
    Diagnostics (Basel); 2022 May; 12(5):. PubMed ID: 35626359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of non-invasive biomarkers for chronic atrophic gastritis from serum exosomal microRNAs.
    Liu H; Li PW; Yang WQ; Mi H; Pan JL; Huang YC; Hou ZK; Hou QK; Luo Q; Liu FB
    BMC Cancer; 2019 Feb; 19(1):129. PubMed ID: 30736753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CSF Proteomics in Patients With Progressive Supranuclear Palsy.
    Wise A; Li J; Yamakawa M; Loureiro J; Peterson B; Worringer K; Sivasankaran R; Palma JA; Mitic L; Heuer HW; Lario-Lago A; Staffaroni AM; Clark A; Taylor J; Ljubenkov PA; Vandevrede L; Grinberg LT; Spina S; Seeley WW; Miller BL; Boeve BF; Dickerson BC; Grossman M; Litvan I; Pantelyat A; Tartaglia MC; Zhang Z; Wills AA; Rexach J; Rojas JC; Boxer AL;
    Neurology; 2024 Aug; 103(3):e209585. PubMed ID: 38959435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diagnosis of progressive supranuclear palsy: current opinions and challenges.
    Ali F; Josephs K
    Expert Rev Neurother; 2018 Jul; 18(7):603-616. PubMed ID: 29902389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salivary microRNA miR-let-7a-5p and miR-3928 could be used as potential diagnostic bio-markers for head and neck squamous cell carcinoma.
    Fadhil RS; Wei MQ; Nikolarakos D; Good D; Nair RG
    PLoS One; 2020; 15(3):e0221779. PubMed ID: 32208417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurofilament Light Chain Levels in Frontotemporal Dementia and Progressive Supranuclear Palsy: A Systematic Review.
    Bendstrup N; Hejl AM; Salvesen L
    J Alzheimers Dis; 2022; 87(1):131-140. PubMed ID: 35275542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tau forms in CSF as a reliable biomarker for progressive supranuclear palsy.
    Borroni B; Malinverno M; Gardoni F; Alberici A; Parnetti L; Premi E; Bonuccelli U; Grassi M; Perani D; Calabresi P; Di Luca M; Padovani A
    Neurology; 2008 Nov; 71(22):1796-803. PubMed ID: 18971445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct Lysosomal Network Protein Profiles in Parkinsonian Syndrome Cerebrospinal Fluid.
    Boman A; Svensson S; Boxer A; Rojas JC; Seeley WW; Karydas A; Miller B; Kågedal K; Svenningsson P
    J Parkinsons Dis; 2016 Apr; 6(2):307-15. PubMed ID: 27061067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Divergent CSF τ alterations in two common tauopathies: Alzheimer's disease and progressive supranuclear palsy.
    Wagshal D; Sankaranarayanan S; Guss V; Hall T; Berisha F; Lobach I; Karydas A; Voltarelli L; Scherling C; Heuer H; Tartaglia MC; Miller Z; Coppola G; Ahlijanian M; Soares H; Kramer JH; Rabinovici GD; Rosen HJ; Miller BL; Meredith J; Boxer AL
    J Neurol Neurosurg Psychiatry; 2015 Mar; 86(3):244-50. PubMed ID: 24899730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum neurofilament light chain in progressive supranuclear palsy.
    Donker Kaat L; Meeter LH; Chiu WZ; Melhem S; Boon AJW; Blennow K; Zetterberg H; van Swieten JC
    Parkinsonism Relat Disord; 2018 Nov; 56():98-101. PubMed ID: 29937097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of [
    Oliveira Hauer K; Pawlik D; Leuzy A; Janelidze S; Hall S; Hansson O; Smith R
    Parkinsonism Relat Disord; 2023 Jan; 106():105226. PubMed ID: 36442367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTPRC Expression in Blood is Downregulated in Parkinson's and Progressive Supranuclear Palsy Disorders.
    Bottero V; Santiago JA; Potashkin JA
    J Parkinsons Dis; 2018; 8(4):529-537. PubMed ID: 30248063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.